Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market - A Global and Regional Analysis: Focus on Therapy Type, Stage of Cachexia, Distribution Channel, and Region - Analysis and ...

DUBLIN--(BUSINESS WIRE)--The "Cachexia - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering. The report offers comprehensive insights of the pipeline (under ...

Tumor growth is associated with profound metabolic and neurochemical alterations, which can lead to the onset of anorexia−cachexia syndrome. Anorexia is defined as the loss of the desire to eat, while ...

Significant progress in our understanding of cancer cachexia has occurred in recent years. Despite these advances, no pharmacologic agent has achieved US Food and Drug Administration approval for this ...

Scientists at São Paulo State University (UNESP) in Brazil, along with colleagues from the University of Southern Denmark, and the University of Antioquia’s Medical School in Colombia, say they have ...

The extreme weight loss seen in many late-stage cancer patients, known as cachexia, is far more than a cosmetic side effect.

Towards the final stages of diseases such as cancer and kidney disease, many patients develop cachexia, a devastating condition in which muscle mass and fat reserves waste away, leading to ...

Please provide your email address to receive an email when new articles are posted on . Patients with cancer cachexia assigned ponsegromab gained significantly more weight than those assigned placebo.

(MENAFN- GlobeNewsWire - Nasdaq) Despite challenges like the absence of FDA-approved therapies, the market offers significant opportunities for innovative disease-modifying solutions. Key industry ...